<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Risk factors, comorbidities, and consequences of insomnia in adults
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Risk factors, comorbidities, and consequences of insomnia in adults
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Risk factors, comorbidities, and consequences of insomnia in adults
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael H Bonnet, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Donna L Arand, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ruth Benca, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            April F Eichler, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 23, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with insomnia have difficulty initiating sleep, difficulty maintaining sleep, or waking up early in the morning without the ability to return to sleep, and they also suffer from significant daytime symptoms such as fatigue, sleepiness, inattention, mood disturbance, or impaired performance [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Insomnia is one of the most common symptoms encountered in medical practice. In addition to immediate consequences reported by patients, insomnia also precedes or accompanies medical or psychiatric disorders and may occur as a response to physiologic or psychological stressors.
        </p>
        <p>
         This topic provides a general overview of the epidemiology, risk factors, comorbidities, and consequences of insomnia. The evaluation, diagnosis and management of insomnia are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7676.html" rel="external">
          "Evaluation and diagnosis of insomnia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/97867.html" rel="external">
          "Overview of the treatment of insomnia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/97869.html" rel="external">
          "Cognitive behavioral therapy for insomnia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/97868.html" rel="external">
          "Pharmacotherapy for insomnia in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insomnia is a common medical complaint that generates over five million office visits per year in the United States alone [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Prevalence estimates vary according to the study design and definition of insomnia used. In cross-sectional surveys of ambulatory patients, one-third to two-thirds of adults report insomnia symptoms of any severity, and approximately 10 to 15 percent have chronic insomnia with daytime consequences [
         <a href="#rid3">
          3-7
         </a>
         ].
        </p>
        <p>
         Insomnia is especially common in older adults and women. Prevalence is also increased among individuals who are unemployed, divorced, widowed, separated, or of lower socioeconomic status [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1458608077">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic insomnia is associated with physiological activation, even in the absence of a comorbid medical or psychiatric condition. A majority of studies have found increases in physiological activation, including cardiac, metabolic, hormone, and high frequency electroencephalographic (EEG) measures [
         <a href="#rid9">
          9
         </a>
         ]. Studies have shown increased activity during sleep in hypothalamic areas and occasional reduced hippocampal volume in patients with insomnia compared with controls [
         <a href="#rid10">
          10,11
         </a>
         ].
        </p>
        <p>
         In studies of healthy volunteers, experimentally-imposed physiological activation produces the poor sleep, daytime dysphoria (including fatigue without objective sleepiness), increased metabolic rate, and anxiety symptoms characteristic of chronic insomnia patients [
         <a href="#rid12">
          12
         </a>
         ], while simple production of an insomnia sleep pattern results only in symptoms of mild sleep deprivation [
         <a href="#rid13">
          13
         </a>
         ]. These results imply that poor sleep in insomnia patients may reflect central nervous system activation rather than a primary sleep problem. An animal study of situational (stress) insomnia suggested that specific brain arousal sites are impacted by stress and associated with poor sleep [
         <a href="#rid14">
          14
         </a>
         ]. Modification of these brain arousal areas was associated with improved sleep after a similar stress. A series of studies have shown that more severe insomnia, as indicated by objective total sleep time of less than six hours, is associated with significant pathophysiology not seen in insomnia patients with longer objective sleep times [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          RISK FACTORS AND COMORBIDITIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insomnia has a complex relationship with other medical and psychiatric disorders and is no longer considered "primary" or "secondary" depending on the presence or absence of an associated condition. In practice, the vast majority of patients have one or more risk factors or comorbidities that may be contributing to insomnia, and successful treatment requires attention to the insomnia itself as well as relevant comorbidities  (
         <a class="graphic graphic_table graphicRef50646" href="/z/d/graphic/50646.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H3796701092">
         <span class="h2">
          Intrinsic factors and genetics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insomnia may be more common among people with a physiological or psychological vulnerability. Individual factors associated with an increased risk of insomnia include [
         <a href="#rid16">
          16,17
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Older age
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Female sex (especially peri- and postmenopausal)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Previous episode of insomnia
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Family history of insomnia
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Predisposition toward being more easily aroused from sleep
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Trait sleep reactivity (ie, the propensity for exaggerated sleep disruption in response to stressful events)
        </p>
        <p>
        </p>
        <p>
         A genetic basis for insomnia is not well characterized and is likely complex. Genome-wide association studies have identified a large number of potentially implicated loci, which overlap with risk profiles for depression, anxiety, neuroticism, type 2 diabetes, coronary artery disease, and low subjective well-being [
         <a href="#rid18">
          18,19
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H371661727">
         <span class="h2">
          Psychiatric disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic insomnia and psychiatric disorders frequently coexist [
         <a href="#rid20">
          20
         </a>
         ]. Approximately half of patients with chronic insomnia have a psychiatric disorder, and the majority of those with a psychiatric disorder have insomnia [
         <a href="#rid3">
          3,21
         </a>
         ].
        </p>
        <p>
         It can be challenging to identify psychiatric comorbidities in patients with insomnia, as patients may deny or minimize the role of the psychiatric disorder. As an example, a patient might say, "I would not be depressed if I could get a good night of sleep." Clinicians, on the other hand, may have a tendency to assume that insomnia is caused by the psychiatric disorder and focus more on the psychiatric condition, with the expectation that the insomnia will improve as the psychiatric condition improves. This may be a false assumption, as insomnia often persists independently.
        </p>
        <p>
         Insomnia frequently precedes the development of psychiatric illness [
         <a href="#rid22">
          22-24
         </a>
         ]. In prospective studies, individuals with insomnia are at significantly increased risk of developing a new psychiatric disorder (particularly major depression) within one year compared with individuals without insomnia.
        </p>
        <p class="headingAnchor" id="H886458995">
         <span class="h3">
          Depression
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insomnia (or hypersomnia), when it exists along with depressed mood or loss of interest or pleasure, is one of nine diagnostic symptoms of unipolar major depression. Around 40 percent of people with insomnia have clinical depression, and up to 80 percent of patients with depression report insomnia symptoms, which frequently predate the development of depression [
         <a href="#rid23">
          23-25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1721.html" rel="external">
          "Unipolar depression in adults: Assessment and diagnosis"
         </a>
         .)
        </p>
        <p>
         Early morning awakening is a hallmark symptom of depression, but adolescents and young adults with depression may report difficulty initiating sleep instead. Depressed patients may also complain that they have not slept at all for one or more nights, although sleep recordings of these nights show reduced (not absent) sleep. Depression is variably associated with a reduced latency to rapid eye movement (REM) sleep, including increased REM sleep in the first one-third of the night. (See
         <a class="medical medical_review" href="/z/d/html/7710.html" rel="external">
          "Stages and architecture of normal sleep"
         </a>
         .)
        </p>
        <p>
         Treatment effects are also bidirectional but may be incomplete, and directed treatment of each disorder may be required. In a meta-analysis of 23 trials of nonpharmacologic or pharmacologic treatment for insomnia in patients with comorbid depression, insomnia therapy led to moderate to large improvements in depression outcomes as measured by the Hamilton or Beck depression scales [
         <a href="#rid26">
          26
         </a>
         ]. Simultaneous treatment of both disorders can increase the likelihood of an insomnia response and lead to more rapid control of depression at lower doses of antidepressant medication [
         <a href="#rid27">
          27
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/97867.html" rel="external">
          "Overview of the treatment of insomnia in adults", section on 'Patients with comorbid psychiatric disorders'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H929246109">
         <span class="h3">
          Anxiety
         </span>
         <span class="headingEndMark">
          —
         </span>
         Like depression, anxiety disorders share diagnostic overlap with insomnia. The majority of patients with anxiety report insomnia [
         <a href="#rid28">
          28
         </a>
         ]. Overall, anxiety disorders including generalized anxiety and posttraumatic stress are associated with increased subjective sleep disturbance, decreased total sleep time, and decreased sleep continuity [
         <a href="#rid29">
          29
         </a>
         ]. Treatment of both anxiety and sleep symptoms improves outcomes [
         <a href="#rid30">
          30
         </a>
         ]. Insomnia can develop before, at the same time, or after the onset of anxiety [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/496.html" rel="external">
          "Generalized anxiety disorder in adults: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/108804.html" rel="external">
          "Management of panic disorder with or without agoraphobia in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H196516592">
         <span class="h3">
          Substance use disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insomnia is very common among patients with substance use disorders across a variety of substances and stages of illness. It predates alcohol dependency in the majority of patients with alcohol use disorder and is an important risk factor for relapse to drinking among those who have achieved abstinence [
         <a href="#rid31">
          31-34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/97847.html" rel="external">
          "Insomnia in patients with a substance use disorder"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H316923213">
         <span class="h3">
          Posttraumatic stress disorder
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with posttraumatic stress disorder (PTSD) frequently have insomnia. Specifically, one review estimated that 70 to 90 percent of patients with PTSD have difficulty falling or staying asleep [
         <a href="#rid35">
          35
         </a>
         ]. This is frequently associated with nightmares and fear of falling asleep or returning to sleep [
         <a href="#rid34">
          34-37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/500.html" rel="external">
          "Posttraumatic stress disorder in adults: Epidemiology, pathophysiology, clinical features, assessment, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/97872.html" rel="external">
          "Nightmares and nightmare disorder in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3539835891">
         <span class="h2">
          Medical conditions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insomnia that follows a chronic course can be comorbid with a medical illness or related to the medications required to treat the medical illness  (
         <a class="graphic graphic_table graphicRef50646" href="/z/d/graphic/50646.html" rel="external">
          table 1
         </a>
         ). Approximately 10 percent of patients with insomnia lasting greater than one month have a coexisting medical condition or take medication [
         <a href="#rid3">
          3
         </a>
         ]. Conversely, approximately 40 percent of patients with a medical problem have insomnia that follows a chronic course, compared with 8 percent in a control population [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
         Medical conditions that are often associated with chronic insomnia include pulmonary disease, hypertension, diabetes, cancer, chronic pain, and heart failure.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary disease
         </strong>
         – 25 to 50 percent of patients with pulmonary disease report insomnia [
         <a href="#rid38">
          38
         </a>
         ]. In addition, COPD symptoms and frequency of acute exacerbation are related to severity of insomnia [
         <a href="#rid39">
          39
         </a>
         ]. The high prevalence of insomnia in this patient population may be related to events that occur when the patient lies down and tries to fall asleep, such as increased work of breathing, pooling of secretions in the airways, and nocturnal bronchoconstriction. Insomnia may also be related to respiratory stimulant medications or glucocorticoids taken during the night.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypertension
         </strong>
         –
         <strong>
         </strong>
         Hypertension and insomnia frequently co-occur [
         <a href="#rid38">
          38
         </a>
         ]. In addition, patients with chronic insomnia have been shown to have increased systolic and diastolic blood pressure during sleep (lack of nocturnal dip) [
         <a href="#rid40">
          40
         </a>
         ]. Insomnia with and without decreased total sleep time has been associated with an increased risk of hypertension and cardiovascular disease [
         <a href="#rid41">
          41-43
         </a>
         ]. (See
         <a class="local">
          'Cardiovascular risk and mortality'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diabetes
         </strong>
         – Insomnia has been reported in up to half of patients with diabetes [
         <a href="#rid38">
          38
         </a>
         ]. This could be due in part to discomfort associated with diabetic neuropathy. In at least one large study, insomnia with reduced objective total sleep time has been identified as an independent risk factor for diabetes [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cancer
         </strong>
         – The prevalence of insomnia in patients with cancer is 30 to 50 percent [
         <a href="#rid45">
          45
         </a>
         ]. Contributing factors may include pain and other physical symptoms, side effects of treatment, emotional distress and psychiatric comorbidities, and the effects of hospitalization. (See
         <a class="medical medical_review" href="/z/d/html/89189.html" rel="external">
          "Insomnia in palliative care"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chronic pain
         </strong>
         – Approximately 75 percent of patients with chronic pain have symptoms of insomnia [
         <a href="#rid46">
          46
         </a>
         ]. Predictors of insomnia in patients with chronic musculoskeletal pain include the presence of widespread pain, physical limitations, and reduced social participation [
         <a href="#rid47">
          47
         </a>
         ]. Even short-term treatment for insomnia can be associated with long-term improvement in sleep, chronic pain, and fatigue [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Heart failure
         </strong>
         – Approximately 30 percent of patients with heart failure may have insomnia [
         <a href="#rid49">
          49
         </a>
         ]. The insomnia may be related to Cheyne-Stokes breathing or frequent awakenings due to nocturia caused by use of a diuretic. Insomnia and frequent awakenings have also been associated with an increased risk of atrial fibrillation [
         <a href="#rid50">
          50,51
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7682.html" rel="external">
          "Sleep-disordered breathing in heart failure"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Others
         </strong>
         – Insomnia is observed with increased frequency in patients with rheumatologic disease (eg, arthritis, fibromyalgia), ischemic heart disease, urologic disease (eg, benign prostatic hyperplasia), endocrine disease (eg, menopause, hyperthyroidism), kidney disease, dermatologic disorders (eg, pruritus), and gastrointestinal disease (eg, gastroesophageal reflux).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2236272698">
         <span class="h2">
          Neurologic disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insomnia is common in patients with neurologic disease. Among patients with Parkinson disease, over 80 percent report sleep disturbances [
         <a href="#rid52">
          52
         </a>
         ]. The deterioration of sleep may be exacerbated by the development of REM sleep behavior disorder [
         <a href="#rid53">
          53
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4903.html" rel="external">
          "Clinical manifestations of Parkinson disease"
         </a>
         .)
        </p>
        <p>
         Patients with insomnia are at increased risk for development of dementia [
         <a href="#rid54">
          54
         </a>
         ], and studies suggest that beta-amyloid and inflammation levels are also increased [
         <a href="#rid55">
          55
         </a>
         ]. Among patients with Alzheimer disease dementia, approximately 25 percent have insomnia [
         <a href="#rid56">
          56
         </a>
         ]. Continuing insomnia may be related to nocturnal agitation, delirium, and wandering, all of which may be related to increased stage 1 sleep and awakenings, which may produce further brain damage. (See
         <a class="medical medical_review" href="/z/d/html/97863.html" rel="external">
          "Sleep-wake disturbances and sleep disorders in patients with dementia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1582169839">
         <span class="h2">
          Medication and substances
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of medications can be associated with insomnia  (
         <a class="graphic graphic_table graphicRef50646" href="/z/d/graphic/50646.html" rel="external">
          table 1
         </a>
         ). Commonly implicated classes of medications and substances include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Central nervous system stimulants, such as caffeine,
         <a class="drug drug_general" data-topicid="9638" href="/z/d/drug information/9638.html" rel="external">
          methylphenidate
         </a>
         ,
         <a class="drug drug_general" data-topicid="99959" href="/z/d/drug information/99959.html" rel="external">
          amphetamine
         </a>
         and
         <a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">
          modafinil
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory stimulants, such as
         <a class="drug drug_general" data-topicid="10281" href="/z/d/drug information/10281.html" rel="external">
          theophylline
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Appetite suppressants.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antidepressants.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Monoamine oxidase inhibitor antidepressants are associated with insomnia in nearly 70 percent of patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Selective serotonin reuptake inhibitors, such as
         <a class="drug drug_general" data-topicid="8465" href="/z/d/drug information/8465.html" rel="external">
          fluoxetine
         </a>
         , are associated with insomnia in 5 to 35 percent of patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Norepinephrine and dopamine reuptake inhibitors, such as
         <a class="drug drug_general" data-topicid="9171" href="/z/d/drug information/9171.html" rel="external">
          bupropion
         </a>
         , are associated with insomnia in 5 to 20 percent of patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Serotonin and norepinephrine reuptake inhibitors, such as
         <a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">
          venlafaxine
         </a>
         , are associated with insomnia in 4 to 18 percent of patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Most tricyclic antidepressants are sedating, but some (eg,
         <a class="drug drug_general" data-topicid="9832" href="/z/d/drug information/9832.html" rel="external">
          protriptyline
         </a>
         ) can produce insomnia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beta blockers, such as
         <a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">
          propranolol
         </a>
         ,
         <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">
          metoprolol
         </a>
         , and
         <a class="drug drug_general" data-topicid="9774" href="/z/d/drug information/9774.html" rel="external">
          pindolol
         </a>
         , can produce sleep-onset insomnia, increased awakenings, and dreams.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glucocorticoids, such as
         <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">
          prednisone
         </a>
         and
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         , are associated with increased wakefulness during the night [
         <a href="#rid57">
          57
         </a>
         ]. Insomnia may occur in 50 to 70 percent of patients who receive prednisone.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alcohol, caffeine, and tobacco.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Over-the-counter medications, such as nasal decongestants and cold medicine.
        </p>
        <p>
        </p>
        <p>
         Medications whose withdrawal can cause insomnia include sedatives, hypnotics, and glucocorticoids.
        </p>
        <p class="headingAnchor" id="H1267349209">
         <span class="h2">
          Other sleep disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insomnia symptoms may co-occur with other sleep disorders, especially sleep apnea, restless legs syndrome (RLS), and circadian sleep-wake rhythm disorders.
        </p>
        <p class="headingAnchor" id="H788700835">
         <span class="h3">
          Sleep apnea
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with sleep apnea have pauses in respiration during sleep that are frequently associated with brief arousals when they resume respiration. As a result, they often report frequent awakenings, poor sleep, or daytime deficits. Approximately 50 to 55 percent of patients being evaluated for sleep apnea report insomnia [
         <a href="#rid58">
          58
         </a>
         ]. Conversely, nearly 30 percent of patients with insomnia have sleep apnea [
         <a href="#rid59">
          59
         </a>
         ]. This proportion is even higher in patients with chronic, treatment-refractory insomnia referred to a sleep center; in such patients, the prevalence of sleep-disordered breathing has been reported to be as high as 90 percent [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
         In some cases, the insomnia does not improve despite successful treatment of the sleep apnea, indicating that the insomnia may be a comorbidity and not a consequence of sleep apnea. In these cases, additional therapy for insomnia may be indicated. (See
         <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">
          "Clinical presentation and diagnosis of obstructive sleep apnea in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7701.html" rel="external">
          "Central sleep apnea: Risk factors, clinical presentation, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4147526975">
         <span class="h3">
          Restless legs syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         RLS is characterized by an urge to move the legs, accompanied by sensations that are variably described as creeping, crawling, itching, or jitteriness in the legs. Symptoms emerge during periods of inactivity and are most prominent in the evening. As a result, an estimated 85 percent of patients with RLS have difficulty falling asleep [
         <a href="#rid61">
          61
         </a>
         ]. Patients are also likely to wake frequently during the night with discomfort in their legs. (See
         <a class="medical medical_review" href="/z/d/html/4892.html" rel="external">
          "Clinical features and diagnosis of restless legs syndrome and periodic limb movement disorder in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4178905806">
         <span class="h3">
          Periodic limb movements of sleep
         </span>
         <span class="headingEndMark">
          —
         </span>
         Periodic limb movements of sleep (PLMS) are repetitive and highly stereotyped limb movements during sleep. They usually involve the legs and occasionally involve the arms. PLMS may be accompanied by partial arousals, causing sleep fragmentation and difficulty maintaining sleep, although there is controversy among clinicians about whether PLMS alone contribute to insomnia in the absence of RLS. (See
         <a class="medical medical_review" href="/z/d/html/4892.html" rel="external">
          "Clinical features and diagnosis of restless legs syndrome and periodic limb movement disorder in adults", section on 'Periodic limb movements of sleep'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1734814824">
         <span class="h3">
          Circadian rhythm sleep-wake disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Jet lag causes insomnia with an acute course. Night shift work is also commonly associated with insomnia, as individuals are attempting to sleep when their circadian rhythm is promoting wakefulness. (See
         <a class="medical medical_review" href="/z/d/html/7686.html" rel="external">
          "Jet lag"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/97846.html" rel="external">
          "Sleep-wake disturbances in shift workers"
         </a>
         .)
        </p>
        <p>
         Less common circadian disorders, such as delayed sleep-wake phase disorder and advanced sleep-wake phase disorder, also commonly manifest with insomnia symptoms due to misalignment of the circadian system with the desired sleep schedule. The key to suspecting an underlying circadian disorder is recognition of abnormal sleep-wake patterns, above and beyond the complaint of insomnia or daytime sleepiness. (See
         <a class="medical medical_review" href="/z/d/html/97844.html" rel="external">
          "Overview of circadian rhythm sleep-wake disorders", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          ADVERSE OUTCOMES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic insomnia has an adverse impact on daytime function and quality of life, and insomnia with objective short sleep duration is associated with increased cardiovascular risk and mortality.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Quality of life
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with insomnia report increased fatigue, sleepiness, confusion, tension, anxiety, and depression compared with controls [
         <a href="#rid9">
          9
         </a>
         ]. Such dysphoria pervades other areas of life, causing patients with insomnia to report a decreased quality of life and degraded performance.
        </p>
        <p>
         Patients with insomnia have decrements in both medical and emotional aspects of life, as determined by a standard measure of quality of life, the Medical Outcomes Study Short Form (SF-36) [
         <a href="#rid62">
          62
         </a>
         ]. The magnitude of the impairment was similar to that seen in patients with a chronic medical condition (eg, heart failure) or depression.
        </p>
        <p>
         Quality of life can also be measured by looking at employment measures, such as promotions and sick time. Patients with insomnia are less likely to receive promotions and more likely to have errors or accidents, to be absent from work, and to have more health-related consequences [
         <a href="#rid9">
          9,63
         </a>
         ]. The poor work performance, increased medical issues, and increased emotional burden associated with insomnia increase costs to society [
         <a href="#rid64">
          64,65
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Cognitive function and performance
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with insomnia are almost universally concerned that their poor sleep has negative consequences on their performance of daily tasks and consistently report subjective performance deficits [
         <a href="#rid66">
          66,67
         </a>
         ]. However, patients with insomnia tend to overestimate the magnitude of the performance deficit, just as they tend to overestimate the magnitude of their sleep deficits.
        </p>
        <p>
         A meta-analysis of 24 studies found small differences in episodic memory, problem solving, and working memory in patients with insomnia compared with controls [
         <a href="#rid68">
          68
         </a>
         ]. No differences were found in general cognitive function, perceptual and psychomotor processes, procedural learning, verbal functions, attention (including alertness, reaction time, selective or sustained attention), and executive function (verbal fluency or cognitive flexibility). However, patients with more severe insomnia, including significant reduction in sleep duration, are at increased risk for cognitive impairment [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5982679">
         <span class="h2">
          Self-medication
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients who do not receive treatment for insomnia frequently seek over-the-counter remedies and have an increased risk of substance abuse [
         <a href="#rid28">
          28
         </a>
         ]. In untreated insomnia patients, approximately one-quarter have tried alcohol as a treatment [
         <a href="#rid69">
          69
         </a>
         ]. In an experimental study among volunteers with insomnia, alcohol increased total sleep time and slow wave sleep for a few nights, but these effects were lost by night six, and blinded subjects became more likely to self-administer alcohol compared with controls [
         <a href="#rid70">
          70
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7809.html" rel="external">
          "Risky drinking and alcohol use disorder: Epidemiology, clinical features, adverse consequences, screening, and assessment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3820830770">
         <span class="h2">
          Association with suicide
         </span>
         <span class="headingEndMark">
          —
         </span>
         In longitudinal studies, insomnia has been associated with a small to moderate increase in the risk of suicidal thoughts and behaviors [
         <a href="#rid71">
          71
         </a>
         ]. Some studies have suggested that the association is primarily mediated by underlying depression, while in other studies, the association is present even after adjusting for psychiatric comorbidities [
         <a href="#rid72">
          72
         </a>
         ]. Other potential contributing factors and mediators include serotonergic dysfunction, dysfunctional beliefs and attitudes about sleep, cognitive dysfunction, and medications and substance misuse [
         <a href="#rid73">
          73,74
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/97868.html" rel="external">
          "Pharmacotherapy for insomnia in adults", section on 'Shared warnings and precautions'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Cardiovascular risk and mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insomnia is associated with sympathetic nervous system activation, and a number of studies have shown an association between insomnia and elevated cardiovascular risk, including hypertension and myocardial infarction [
         <a href="#rid41">
          41,75-82
         </a>
         ]. In particular, the combination of chronic insomnia and decreased objective total sleep time has been associated with increased risk for hypertension [
         <a href="#rid78">
          78,83,84
         </a>
         ] and incident cardiovascular disease [
         <a href="#rid42">
          42
         </a>
         ], and patients with insomnia have been observed to have a non-dipping blood pressure pattern at night [
         <a href="#rid40">
          40
         </a>
         ] that can improve with insomnia treatment [
         <a href="#rid85">
          85
         </a>
         ]. Several prospective observational studies have shown an increased risk of cardiovascular disease and, in some cases, overall mortality in patients with insomnia that remains significant after adjusting for potential confounders [
         <a href="#rid42">
          42,81,86,87
         </a>
         ].
        </p>
        <p>
         Patients with insomnia and short nocturnal sleep time are at increased risk for diabetes [
         <a href="#rid44">
          44
         </a>
         ], and treatment of insomnia in patients with diabetes has improved both sleep efficiency and glycemic control as measured by HbA1c in at least one study [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p>
         The physiological activation associated with chronic objective insomnia likely accounts for the association between insomnia and hypertension, cardiovascular disease, diabetes, and metabolic disorder [
         <a href="#rid42">
          42,89,90
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3510154054">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113803.html" rel="external">
          "Society guideline links: Insomnia in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/7717.html" rel="external">
          "Patient education: Insomnia (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/7718.html" rel="external">
          "Patient education: Insomnia treatments (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – One-third to two-thirds of adults report insomnia symptoms of any severity, and approximately 10 to 15 percent have chronic insomnia with daytime consequences. Insomnia is especially common in older adults and women. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Intrinsic factors and genetics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors and comorbidities
         </strong>
         – Insomnia has a complex relationship with other medical and psychiatric disorders and is no longer considered "primary" or "secondary" depending on the presence or absence of an associated condition. Successful treatment requires attention to the insomnia itself as well as relevant comorbidities  (
         <a class="graphic graphic_table graphicRef50646" href="/z/d/graphic/50646.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Risk factors and comorbidities'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Psychiatric disorders
         </strong>
         – Approximately half of patients with chronic insomnia have a psychiatric disorder, and the majority of those with a psychiatric disorder have insomnia. Frequent comorbidities include mood disorders, substance use disorders, and posttraumatic stress disorder. (See
         <a class="local">
          'Psychiatric disorders'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Medical conditions
         </strong>
         – High-risk medical conditions for chronic insomnia include pulmonary disease, hypertension, diabetes, cancer, chronic pain, and heart failure. (See
         <a class="local">
          'Medical conditions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Neurologic disorders
         </strong>
         – Neurodegenerative disorders including dementia and Parkinson disease are frequently accompanied by sleep disturbances and chronic insomnia. (See
         <a class="local">
          'Neurologic disorders'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Medications
         </strong>
         – Medications and substances contribute to chronic insomnia in many patients. Commonly implicated classes include central nervous system stimulants, certain antidepressants, glucocorticoids, alcohol, tobacco, and caffeine.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other sleep disorders
         </strong>
         – Insomnia symptoms commonly co-occur with other sleep disorders, especially sleep apnea, restless legs syndrome (RLS), and circadian sleep-wake rhythm disorders.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adverse outcomes
         </strong>
         – Sequelae of insomnia include decreased quality of life, complaints of impaired daytime performance, and increased risk of medical and psychiatric comorbidities. (See
         <a class="local">
          'Adverse outcomes'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed, text revision, American Academy of Sleep Medicine, 2023.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ford ES, Wheaton AG, Cunningham TJ, et al. Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: findings from the National Ambulatory Medical Care survey 1999-2010. Sleep 2014; 37:1283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002; 6:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care patients. Sleep 1999; 22 Suppl 2:S359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985; 42:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LeBlanc M, Mérette C, Savard J, et al. Incidence and risk factors of insomnia in a population-based sample. Sleep 2009; 32:1027.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klimt F, Jacobi C, Brähler E, et al. Insomnia symptoms in adulthood. Prevalence and incidence over 25 years. Sleep Med 2023; 109:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olfson M, Wall M, Liu SM, et al. Insomnia and Impaired Quality of Life in the United States. J Clin Psychiatry 2018; 79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonnet MH, Arand DL. Consequences of insomnia. Sleep Med Clin 2006; 1:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nofzinger EA, Buysse DJ, Germain A, et al. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 2004; 161:2126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Riemann D, Voderholzer U, Spiegelhalder K, et al. Chronic insomnia and MRI-measured hippocampal volumes: a pilot study. Sleep 2007; 30:955.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonnet MH, Arand DL. Caffeine use as a model of acute and chronic insomnia. Sleep 1992; 15:526.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonnet MH, Arand DL. The consequences of a week of insomnia. Sleep 1996; 19:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cano G, Mochizuki T, Saper CB. Neural circuitry of stress-induced insomnia in rats. J Neurosci 2008; 28:10167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernandez-Mendoza J, He F, Puzino K, et al. Insomnia with objective short sleep duration is associated with cognitive impairment: a first look at cardiometabolic contributors to brain health. Sleep 2021; 44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drake CL, Pillai V, Roth T. Stress and sleep reactivity: a prospective investigation of the stress-diathesis model of insomnia. Sleep 2014; 37:1295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drake CL, Cheng P, Almeida DM, Roth T. Familial Risk for Insomnia Is Associated With Abnormal Cortisol Response to Stress. Sleep 2017; 40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jansen PR, Watanabe K, Stringer S, et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nat Genet 2019; 51:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stein MB, McCarthy MJ, Chen CY, et al. Genome-wide analysis of insomnia disorder. Mol Psychiatry 2018; 23:2238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alvaro PK, Roberts RM, Harris JK. A Systematic Review Assessing Bidirectionality between Sleep Disturbances, Anxiety, and Depression. Sleep 2013; 36:1059.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           National Institutes of Health. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005; 28:1049.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 2003; 37:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989; 262:1479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hertenstein E, Feige B, Gmeiner T, et al. Insomnia as a predictor of mental disorders: A systematic review and meta-analysis. Sleep Med Rev 2019; 43:96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellis JG, Perlis ML, Bastien CH, et al. The natural history of insomnia: acute insomnia and first-onset depression. Sleep 2014; 37:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gebara MA, Siripong N, DiNapoli EA, et al. Effect of insomnia treatments on depression: A systematic review and meta-analysis. Depress Anxiety 2018; 35:717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006; 59:1052.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996; 39:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cox RC, Olatunji BO. Sleep in the anxiety-related disorders: A meta-analysis of subjective and objective research. Sleep Med Rev 2020; 51:101282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pollack M, Kinrys G, Krystal A, et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry 2008; 65:551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Currie SR, Clark S, Rimac S, Malhotra S. Comprehensive assessment of insomnia in recovering alcoholics using daily sleep diaries and ambulatory monitoring. Alcohol Clin Exp Res 2003; 27:1262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brower KJ, Aldrich MS, Robinson EA, et al. Insomnia, self-medication, and relapse to alcoholism. Am J Psychiatry 2001; 158:399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drummond SP, Gillin JC, Smith TL, DeModena A. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res 1998; 22:1796.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanady JC, Talbot LS, Maguen S, et al. Cognitive Behavioral Therapy for Insomnia Reduces Fear of Sleep in Individuals With Posttraumatic Stress Disorder. J Clin Sleep Med 2018; 14:1193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maher MJ, Rego SA, Asnis GM. Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management. CNS Drugs 2006; 20:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lamarche LJ, De Koninck J. Sleep disturbance in adults with posttraumatic stress disorder: a review. J Clin Psychiatry 2007; 68:1257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richards A, Kanady JC, Neylan TC. Sleep disturbance in PTSD and other anxiety-related disorders: an updated review of clinical features, physiological characteristics, and psychological and neurobiological mechanisms. Neuropsychopharmacology 2020; 45:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor DJ, Mallory LJ, Lichstein KL, et al. Comorbidity of chronic insomnia with medical problems. Sleep 2007; 30:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li SQ, Sun XW, Zhang L, et al. Impact of insomnia and obstructive sleep apnea on the risk of acute exacerbation of chronic obstructive pulmonary disease. Sleep Med Rev 2021; 58:101444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lanfranchi PA, Pennestri MH, Fradette L, et al. Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep 2009; 32:760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernandez-Mendoza J, Vgontzas AN, Liao D, et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension 2012; 60:929.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bertisch SM, Pollock BD, Mittleman MA, et al. Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: Sleep Heart Health Study. Sleep 2018; 41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jarrin DC, Alvaro PK, Bouchard MA, et al. Insomnia and hypertension: A systematic review. Sleep Med Rev 2018; 41:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vgontzas AN, Liao D, Pejovic S, et al. Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care 2009; 32:1980.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Büttner-Teleagă A, Kim YT, Osel T, Richter K. Sleep Disorders in Cancer-A Systematic Review. Int J Environ Res Public Health 2021; 18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun Y, Laksono I, Selvanathan J, et al. Prevalence of sleep disturbances in patients with chronic non-cancer pain: A systematic review and meta-analysis. Sleep Med Rev 2021; 57:101467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang NK, McBeth J, Jordan KP, et al. Impact of musculoskeletal pain on insomnia onset: a prospective cohort study. Rheumatology (Oxford) 2015; 54:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vitiello MV, McCurry SM, Shortreed SM, et al. Short-term improvement in insomnia symptoms predicts long-term improvements in sleep, pain, and fatigue in older adults with comorbid osteoarthritis and insomnia. Pain 2014; 155:1547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998; 158:1099.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christensen MA, Dixit S, Dewland TA, et al. Sleep characteristics that predict atrial fibrillation. Heart Rhythm 2018; 15:1289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chokesuwattanaskul R, Thongprayoon C, Sharma K, et al. Associations of sleep quality with incident atrial fibrillation: a meta-analysis. Intern Med J 2018; 48:964.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mantovani S, Smith SS, Gordon R, O'Sullivan JD. An overview of sleep and circadian dysfunction in Parkinson's disease. J Sleep Res 2018; 27:e12673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stefani A, Högl B. Sleep Disorders in Parkinson Disease. Sleep Med Clin 2021; 16:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hung CM, Li YC, Chen HJ, et al. Risk of dementia in patients with primary insomnia: a nationwide population-based case-control study. BMC Psychiatry 2018; 18:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadeghmousavi S, Eskian M, Rahmani F, Rezaei N. The effect of insomnia on development of Alzheimer's disease. J Neuroinflammation 2020; 17:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moran M, Lynch CA, Walsh C, et al. Sleep disturbance in mild to moderate Alzheimer's disease. Sleep Med 2005; 6:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szmyd B, Rogut M, Białasiewicz P, Gabryelska A. The impact of glucocorticoids and statins on sleep quality. Sleep Med Rev 2021; 55:101380.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krell SB, Kapur VK. Insomnia complaints in patients evaluated for obstructive sleep apnea. Sleep Breath 2005; 9:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gooneratne NS, Gehrman PR, Nkwuo JE, et al. Consequences of comorbid insomnia symptoms and sleep-related breathing disorder in elderly subjects. Arch Intern Med 2006; 166:1732.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krakow B, Ulibarri VA, McIver ND. Pharmacotherapeutic failure in a large cohort of patients with insomnia presenting to a sleep medicine center and laboratory: subjective pretest predictions and objective diagnoses. Mayo Clin Proc 2014; 89:1608.
          </a>
         </li>
         <li class="breakAll">
          Montplaisir J, Allen RP, Walters AS, Ferini-Strambi L. Restless legs syndrome and periodic limb movements during sleep. In: Principles and Practice of Sleep Medicine, 4th ed, Kryger M, Roth T, Dement WC (Eds), Saunders, New York 2005. p.839.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract 2002; 51:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Léger D, Massuel MA, Metlaine A, SISYPHE Study Group. Professional correlates of insomnia. Sleep 2006; 29:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007; 30:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daley M, Morin CM, LeBlanc M, et al. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 2009; 32:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vignola A, Lamoureux C, Bastien CH, Morin CM. Effects of chronic insomnia and use of benzodiazepines on daytime performance in older adults. J Gerontol B Psychol Sci Soc Sci 2000; 55:P54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lerner D, Amick BC 3rd, Rogers WH, et al. The Work Limitations Questionnaire. Med Care 2001; 39:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev 2012; 16:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Costa e Silva JA, Chase M, Sartorius N, Roth T. Special report from a symposium held by the World Health Organization and the World Federation of Sleep Research Societies: an overview of insomnias and related disorders--recognition, epidemiology, and rational management. Sleep 1996; 19:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roehrs T, Roth T. Insomnia as a path to alcoholism: tolerance development and dose escalation. Sleep 2018; 41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu RT, Steele SJ, Hamilton JL, et al. Sleep and suicide: A systematic review and meta-analysis of longitudinal studies. Clin Psychol Rev 2020; 81:101895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woznica AA, Carney CE, Kuo JR, Moss TG. The insomnia and suicide link: toward an enhanced understanding of this relationship. Sleep Med Rev 2015; 22:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCall WV, Black CG. The link between suicide and insomnia: theoretical mechanisms. Curr Psychiatry Rep 2013; 15:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCall WV, Benca RM, Rosenquist PB, et al. Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA. Am J Psychiatry 2017; 174:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med 1998; 60:610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health 2003; 45:344.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonnet MH, Arand DL, Javaheri S. Cardiovascular implications of poor sleep. Sleep Med Clin 2007; 2:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vgontzas AN, Liao D, Bixler EO, et al. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 2009; 32:491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonnet MH, Burton GG, Arand DL. Physiological and medical findings in insomnia: implications for diagnosis and care. Sleep Med Rev 2014; 18:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalmbach DA, Pillai V, Arnedt JT, Drake CL. DSM-5 Insomnia and Short Sleep: Comorbidity Landscape and Racial Disparities. Sleep 2016; 39:2101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zheng B, Yu C, Lv J, et al. Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: A 10-year cohort. Neurology 2019; 93:e2110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li X, Sotres-Alvarez D, Gallo LC, et al. Associations of Sleep-disordered Breathing and Insomnia with Incident Hypertension and Diabetes. The Hispanic Community Health Study/Study of Latinos. Am J Respir Crit Care Med 2021; 203:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson KA, Gordon CJ, Chapman JL, et al. The association of insomnia disorder characterised by objective short sleep duration with hypertension, diabetes and body mass index: A systematic review and meta-analysis. Sleep Med Rev 2021; 59:101456.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dai Y, Chen B, Chen L, et al. Insomnia with objective short sleep duration is associated with hypertension. J Sleep Res 2023; 32:e13833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang Y, Mai W, Cai X, et al. The effect of zolpidem on sleep quality, stress status, and nondipping hypertension. Sleep Med 2012; 13:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y, Zhang X, Winkelman JW, et al. Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation 2014; 129:737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parthasarathy S, Vasquez MM, Halonen M, et al. Persistent insomnia is associated with mortality risk. Am J Med 2015; 128:268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garfinkel D, Zorin M, Wainstein J, et al. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes Metab Syndr Obes 2011; 4:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carter JR, Grimaldi D, Fonkoue IT, et al. Assessment of sympathetic neural activity in chronic insomnia: evidence for elevated cardiovascular risk. Sleep 2018; 41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernandez-Mendoza J, He F, LaGrotte C, et al. Impact of the Metabolic Syndrome on Mortality is Modified by Objective Short Sleep Duration. J Am Heart Assoc 2017; 6.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7684 Version 39.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed, text revision, American Academy of Sleep Medicine, 2023.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25083008" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: findings from the National Ambulatory Medical Care survey 1999-2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12531146" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Epidemiology of insomnia: what we know and what we still need to learn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10394608" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Insomnia in primary care patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2858188" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Insomnia and its treatment. Prevalence and correlates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19725254" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Incidence and risk factors of insomnia in a population-based sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37480825" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Insomnia symptoms in adulthood. Prevalence and incidence over 25 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30256547" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Insomnia and Impaired Quality of Life in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Consequences of insomnia
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15514418" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Functional neuroimaging evidence for hyperarousal in insomnia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17702263" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Chronic insomnia and MRI-measured hippocampal volumes: a pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1475567" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Caffeine use as a model of acute and chronic insomnia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8865501" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The consequences of a week of insomnia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18829974" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Neural circuitry of stress-induced insomnia in rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32968796" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Insomnia with objective short sleep duration is associated with cognitive impairment: a first look at cardiometabolic contributors to brain health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25083009" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Stress and sleep reactivity: a prospective investigation of the stress-diathesis model of insomnia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28958055" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Familial Risk for Insomnia Is Associated With Abnormal Cortisol Response to Stress.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30804565" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29520036" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Genome-wide analysis of insomnia disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23814343" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : A Systematic Review Assessing Bidirectionality between Sleep Disturbances, Anxiety, and Depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16268373" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12482465" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Place of chronic insomnia in the course of depressive and anxiety disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2769898" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30537570" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Insomnia as a predictor of mental disorders: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24470699" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : The natural history of insomnia: acute insomnia and first-onset depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29782076" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Effect of insomnia treatments on depression: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16581036" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8679786" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32109832" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Sleep in the anxiety-related disorders: A meta-analysis of subjective and objective research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18458207" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12966320" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Comprehensive assessment of insomnia in recovering alcoholics using daily sleep diaries and ambulatory monitoring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11229980" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Insomnia, self-medication, and relapse to alcoholism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9835298" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29991428" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Cognitive Behavioral Therapy for Insomnia Reduces Fear of Sleep in Individuals With Posttraumatic Stress Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16800716" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17854251" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Sleep disturbance in adults with posttraumatic stress disorder: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31443103" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Sleep disturbance in PTSD and other anxiety-related disorders: an updated review of clinical features, physiological characteristics, and psychological and neurobiological mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17326547" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Comorbidity of chronic insomnia with medical problems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33601330" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Impact of insomnia and obstructive sleep apnea on the risk of acute exacerbation of chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19544752" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22892811" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29522193" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: Sleep Heart Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29576408" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Insomnia and hypertension: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19641160" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34770209" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Sleep Disorders in Cancer-A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33827029" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Prevalence of sleep disturbances in patients with chronic non-cancer pain: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25125589" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Impact of musculoskeletal pain on insomnia onset: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24793909" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Short-term improvement in insomnia symptoms predicts long-term improvements in sleep, pain, and fatigue in older adults with comorbid osteoarthritis and insomnia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9605781" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Clinical correlates of insomnia in patients with chronic illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29958805" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Sleep characteristics that predict atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29460411" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Associations of sleep quality with incident atrial fibrillation: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29493044" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : An overview of sleep and circadian dysfunction in Parkinson's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33985657" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Sleep Disorders in Parkinson Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29415688" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Risk of dementia in patients with primary insomnia: a nationwide population-based case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33023629" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The effect of insomnia on development of Alzheimer's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15978517" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Sleep disturbance in mild to moderate Alzheimer's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33010620" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : The impact of glucocorticoids and statins on sleep quality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16091954" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Insomnia complaints in patients evaluated for obstructive sleep apnea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16983051" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Consequences of comorbid insomnia symptoms and sleep-related breathing disorder in elderly subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25236429" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Pharmacotherapeutic failure in a large cohort of patients with insomnia presenting to a sleep medicine center and laboratory: subjective pretest predictions and objective diagnoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25236429" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Pharmacotherapeutic failure in a large cohort of patients with insomnia presenting to a sleep medicine center and laboratory: subjective pretest predictions and objective diagnoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11978233" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : The relationship between insomnia and health-related quality of life in patients with chronic illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16494084" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Professional correlates of insomnia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17425222" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : The direct and indirect costs of untreated insomnia in adults in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19189779" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10728124" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Effects of chronic insomnia and use of benzodiazepines on daytime performance in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11176545" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : The Work Limitations Questionnaire.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21636297" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Insomnia and daytime cognitive performance: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8843532" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Special report from a symposium held by the World Health Organization and the World Federation of Sleep Research Societies: an overview of insomnias and related disorders--recognition, epidemiology, and rational management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29762764" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Insomnia as a path to alcoholism: tolerance development and dose escalation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32801085" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Sleep and suicide: A systematic review and meta-analysis of longitudinal studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25454672" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : The insomnia and suicide link: toward an enhanced understanding of this relationship.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23949486" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : The link between suicide and insomnia: theoretical mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27609243" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9773766" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Heart rate variability in insomniacs and matched normal sleepers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14676413" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Persistent insomnia is a predictor of hypertension in Japanese male workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Cardiovascular implications of poor sleep
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19413143" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Insomnia with objective short sleep duration is associated with a high risk for hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23751272" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Physiological and medical findings in insomnia: implications for diagnosis and care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27634805" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : DSM-5 Insomnia and Short Sleep: Comorbidity Landscape and Racial Disparities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31694922" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: A 10-year cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32758008" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Associations of Sleep-disordered Breathing and Insomnia with Incident Hypertension and Diabetes. The Hispanic Community Health Study/Study of Latinos.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33640704" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : The association of insomnia disorder characterised by objective short sleep duration with hypertension, diabetes and body mass index: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36704942" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Insomnia with objective short sleep duration is associated with hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22153779" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : The effect of zolpidem on sleep quality, stress status, and nondipping hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24226807" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Association between insomnia symptoms and mortality: a prospective study of U.S. men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25447616" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Persistent insomnia is associated with mortality risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21887103" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29522186" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Assessment of sympathetic neural activity in chronic insomnia: evidence for elevated cardiovascular risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28515112" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Impact of the Metabolic Syndrome on Mortality is Modified by Objective Short Sleep Duration.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
